rAAV-CaV1.3-shRNA

N/A

Report date: 2026/04/13 11:07:52
NME

Base Information

Drug NamerAAV-CaV1.3-shRNA
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > short hairpin RNA
Mechanisms of ActionGene silencing
TargetsVoltage-dependent L-type calcium channel subunit alpha-1D
Therapy Area/IndicationsLevodopa-induced dyskinesia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMichigan State University
China Registration ClassN/A

Develop Information

Active CompaniesMichigan State University
Inactive CompaniesN/A
Active IndicationsLevodopa-induced dyskinesia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A